Our new whitepaper has just been released! Go check it out!

Schedio Group has released a new white paper exploring spray drying as a potential alternative to freeze drying for biopharmaceuticals. This technical analysis examines the stability challenges of biopharmaceutical formulations and evaluates the feasibility of spray drying for advanced therapeutics, including monoclonal antibodies (mAb) and antibody-drug conjugates (ADC).

The paper provides a detailed comparison of drying technologies, backed by scientific literature and real-world applications.

Download the full white paper on Schedio Group’s website to explore the potential of spray drying in biopharmaceutical manufacturing.

Read the white paper now!